Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biweekly Interval Intermittent Fasting for Type 2 Diabetes, a Safety Study

NCT03938441 is registered in ClinicalTrials.gov with gino gaddini as lead sponsor.

NCT NCT03938441
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03938441 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biweekly Interval Intermittent Fasting for Type 2 Diabetes, a Safety Study
Lead sponsor
gino gaddini
Phase
Not applicable
Overall status
Terminated
Start date
July 31, 2019
Completion date
May 28, 2021
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes type 2, pre-diabetes